SCHEMBL23837447

SCHEMBL23837447

CS(=O)(=O)CCCC(=O)N[C@H]1Cc2cccc(C(=O)O)c2OB1N=O

nearest known ligand 0.43

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17336963 0.87 MAPT (0.33) MAPT
SCHEMBL17336965 0.87 MAPT (0.33) MAPT
SCHEMBL23837318 0.87 ACLY (0.30) —
SCHEMBL23837330 0.83 PARP1 (0.30) —
SCHEMBL23837477 0.83 PARP1 (0.38) MAPT
SCHEMBL17337125 0.81 PARP1 (0.32) MAPT
SCHEMBL17337128 0.81 PARP1 (0.32) MAPT
SCHEMBL23837340 0.81 HPGD (0.33) MAPT
SCHEMBL23837322 0.81 MTNR1A (0.32) —
SCHEMBL23837337 0.81 AAK1 (0.33) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3882252-A1 BETA-LACTAMASE INHIBITORS Venatorx Pharmaceuticals, Inc. (US) 2021-09-22 — — EP disclosed
Send feedback